These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8994219)

  • 1. Corticotropin-releasing factor receptor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats.
    Smagin GN; Harris RB; Ryan DH
    Neurosci Lett; 1996 Dec; 220(3):167-70. PubMed ID: 8994219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prenatal stress on defensive withdrawal behavior and corticotropin releasing factor systems in rat brain.
    Ward HE; Johnson EA; Salm AK; Birkle DL
    Physiol Behav; 2000; 70(3-4):359-66. PubMed ID: 11006435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal behavior in rats.
    Yang XM; Gorman AL; Dunn AJ
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1064-70. PubMed ID: 2262892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-Releasing Factor Mediates Pain-Induced Anxiety through the ERK1/2 Signaling Cascade in Locus Coeruleus Neurons.
    Borges GP; Micó JA; Neto FL; Berrocoso E
    Int J Neuropsychopharmacol; 2015 Feb; 18(8):. PubMed ID: 25716783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of corticotropin-releasing factor receptors in the locus coeruleus attenuates shock-induced freezing in rats.
    Swiergiel AH; Takahashi LK; Rubin WW; Kalin NH
    Brain Res; 1992 Aug; 587(2):263-8. PubMed ID: 1326376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
    J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of corticotropin-releasing hormone on electrophysiological activity of locus coeruleus neurons.
    Borsody MK; Weiss JM
    Brain Res; 1996 Jun; 724(2):149-68. PubMed ID: 8828564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress-induced intracellular trafficking of corticotropin-releasing factor receptors in rat locus coeruleus neurons.
    Reyes BA; Valentino RJ; Van Bockstaele EJ
    Endocrinology; 2008 Jan; 149(1):122-30. PubMed ID: 17947354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRF receptor antagonist attenuates immobilization stress-induced norepinephrine release in the prefrontal cortex in rats.
    Smagin GN; Zhou J; Harris RB; Ryan DH
    Brain Res Bull; 1997; 42(6):431-4. PubMed ID: 9128917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of infusion of corticotropin-releasing factor antagonist into the locus coeruleus on freezing behavior and brain catecholamines in rats.
    Swiergiel AH
    Acta Neurobiol Exp (Wars); 2003; 63(1):9-16. PubMed ID: 12784927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CRF(1) receptor antagonist, NBI-35965, abolished the activation of locus coeruleus neurons induced by colorectal distension and intracisternal CRF in rats.
    Kosoyan HP; Grigoriadis DE; Taché Y
    Brain Res; 2005 Sep; 1056(1):85-96. PubMed ID: 16095571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a benzodiazepine receptor agonist and corticotropin-releasing hormone receptor antagonists on long-term foot-shock-induced increase in defensive withdrawal behavior.
    Bruijnzeel AW; Stam R; Wiegant VM
    Psychopharmacology (Berl); 2001 Nov; 158(2):132-9. PubMed ID: 11702086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of locus coeruleus neuronal activity by interleukin-1 and the involvement of endogenous corticotropin-releasing hormone.
    Borsody MK; Weiss JM
    Neuroimmunomodulation; 2002-2003; 10(2):101-21. PubMed ID: 12372984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing factor in the locus coeruleus as a modulator of ventilation in rats.
    Incheglu JM; Bícego KC; Gargaglioni LH
    Respir Physiol Neurobiol; 2016 Nov; 233():73-80. PubMed ID: 27543446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term regulation of locus ceruleus sensitivity to corticotropin-releasing factor by swim stress.
    Curtis AL; Pavcovich LA; Valentino RJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1211-9. PubMed ID: 10336508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats.
    Lu L; Liu D; Ceng X
    Eur J Pharmacol; 2001 Mar; 415(2-3):203-8. PubMed ID: 11275000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Previous stress alters corticotropin-releasing factor neurotransmission in the locus coeruleus.
    Curtis AL; Pavcovich LA; Grigoriadis DE; Valentino RJ
    Neuroscience; 1995 Mar; 65(2):541-50. PubMed ID: 7777167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pretreatment with corticotropin-releasing factor on the electrophysiological responsivity of the locus coeruleus to subsequent corticotropin-releasing factor challenge.
    Conti LH; Foote SL
    Neuroscience; 1995 Nov; 69(1):209-19. PubMed ID: 8637619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locus coeruleus involvement in the effects of immobilization stress on the p13 midlatency auditory evoked potential in the rat.
    Miyazato H; Skinner RD; Garcia-Rill E
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Oct; 24(7):1177-201. PubMed ID: 11131179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Nakazato A; Kumagai T; Okubo T; Tomisawa K
    J Pharmacol Exp Ther; 1999 May; 289(2):926-35. PubMed ID: 10215672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.